[HTML][HTML] Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific reports, 2018 - nature.com
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - strathprints.strath.ac.uk
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - search.ebscohost.com
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - pubmed.ncbi.nlm.nih.gov
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

[PDF][PDF] Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - SCIENTIFIC …, 2018 - core.ac.uk
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - ui.adsabs.harvard.edu
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - pureportal.strath.ac.uk
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

[HTML][HTML] Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - europepmc.org
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - eprints.gla.ac.uk
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …

[HTML][HTML] Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

T Mulholland, M McAllister, S Patek, D Flint… - Scientific …, 2018 - ncbi.nlm.nih.gov
Performing drug screening of tissue derived from cancer patient biopsies using
physiologically relevant 3D tumour models presents challenges due to the limited amount of …